KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Equity (2019 - 2025)

Historic Return on Equity for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to 0.57%.

  • Vir Biotechnology's Return on Equity fell 1700.0% to 0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.38% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, Vir Biotechnology's Return on Equity stood at 0.57%, which was down 1700.0% from 0.55% recorded in Q2 2025.
  • Vir Biotechnology's 5-year Return on Equity high stood at 0.71% for Q1 2022, and its period low was 0.59% during Q1 2021.
  • For the 5-year period, Vir Biotechnology's Return on Equity averaged around 0.14%, with its median value being 0.34% (2024).
  • As far as peak fluctuations go, Vir Biotechnology's Return on Equity soared by 13000bps in 2022, and later plummeted by -9000bps in 2023.
  • Quarter analysis of 5 years shows Vir Biotechnology's Return on Equity stood at 0.46% in 2021, then plummeted by -47bps to 0.24% in 2022, then crashed by -254bps to 0.38% in 2023, then dropped by -16bps to 0.44% in 2024, then tumbled by -31bps to 0.57% in 2025.
  • Its Return on Equity was 0.57% in Q3 2025, compared to 0.55% in Q2 2025 and 0.53% in Q1 2025.